ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)

Abnormal expression of insulin gene enhancer-binding protein 1 (ISL1) has been demonstrated to be closely associated with cancer development and progression in several cancers. However, little is known about ISL1 expression in metastatic castration-resistant prostate cancer (CRPC). ISL1 has also bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae Duck, Kim, Tae Jin, Jeong, Byong Chang, Jeon, Hwang Gyun, Jeon, Seong Soo, Kang, Min Yong, Yeom, Seon Yong, Seo, Seong Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578390/
https://www.ncbi.nlm.nih.gov/pubmed/34753990
http://dx.doi.org/10.1038/s41598-021-01003-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578390/
https://www.ncbi.nlm.nih.gov/pubmed/34753990
http://dx.doi.org/10.1038/s41598-021-01003-0

Ejemplares similares